MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma

<p>Abstract</p> <p>MiR-106b is frequently up-regulated in various types of human cancer including laryngeal carcinoma. However the underlying mechanism of miR-106b involved in laryngeal carcinoma remains elusive. Here we showed that reduction of miR-106b induced cell cycle G0/G1 ar...

Full description

Bibliographic Details
Main Authors: Bao Xueli, Wang Yu, Cai Kemin
Format: Article
Language:English
Published: BMC 2011-08-01
Series:Journal of Experimental & Clinical Cancer Research
Subjects:
Online Access:http://www.jeccr.com/content/30/1/73
_version_ 1811285176515297280
author Bao Xueli
Wang Yu
Cai Kemin
author_facet Bao Xueli
Wang Yu
Cai Kemin
author_sort Bao Xueli
collection DOAJ
description <p>Abstract</p> <p>MiR-106b is frequently up-regulated in various types of human cancer including laryngeal carcinoma. However the underlying mechanism of miR-106b involved in laryngeal carcinoma remains elusive. Here we showed that reduction of miR-106b induced cell cycle G0/G1 arrest by targeting tumor suppressor RB in human laryngeal carcinoma cells. Further, Introducing RB cDNA without 3'UTR abrogated miR-106b-induced cell proliferation. Finally, there was an inverse relationship between RB and miR-106b expression in laryngeal carcinoma tissues. To our knowledge, these data indicate for the first time that miR-106b directly regulate cell cycle by targeting RB in laryngeal carcinoma and that miR-106b could be potential therapeutic approaches for laryngeal carcinoma.</p>
first_indexed 2024-04-13T02:40:29Z
format Article
id doaj.art-7ec50f984bd948a6a63a3e876d8a678b
institution Directory Open Access Journal
issn 1756-9966
language English
last_indexed 2024-04-13T02:40:29Z
publishDate 2011-08-01
publisher BMC
record_format Article
series Journal of Experimental & Clinical Cancer Research
spelling doaj.art-7ec50f984bd948a6a63a3e876d8a678b2022-12-22T03:06:13ZengBMCJournal of Experimental & Clinical Cancer Research1756-99662011-08-013017310.1186/1756-9966-30-73MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinomaBao XueliWang YuCai Kemin<p>Abstract</p> <p>MiR-106b is frequently up-regulated in various types of human cancer including laryngeal carcinoma. However the underlying mechanism of miR-106b involved in laryngeal carcinoma remains elusive. Here we showed that reduction of miR-106b induced cell cycle G0/G1 arrest by targeting tumor suppressor RB in human laryngeal carcinoma cells. Further, Introducing RB cDNA without 3'UTR abrogated miR-106b-induced cell proliferation. Finally, there was an inverse relationship between RB and miR-106b expression in laryngeal carcinoma tissues. To our knowledge, these data indicate for the first time that miR-106b directly regulate cell cycle by targeting RB in laryngeal carcinoma and that miR-106b could be potential therapeutic approaches for laryngeal carcinoma.</p>http://www.jeccr.com/content/30/1/73laryngeal carcinomamiR-106bRBcell proliferation
spellingShingle Bao Xueli
Wang Yu
Cai Kemin
MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma
Journal of Experimental & Clinical Cancer Research
laryngeal carcinoma
miR-106b
RB
cell proliferation
title MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma
title_full MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma
title_fullStr MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma
title_full_unstemmed MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma
title_short MiR-106b promotes cell proliferation via targeting RB in laryngeal carcinoma
title_sort mir 106b promotes cell proliferation via targeting rb in laryngeal carcinoma
topic laryngeal carcinoma
miR-106b
RB
cell proliferation
url http://www.jeccr.com/content/30/1/73
work_keys_str_mv AT baoxueli mir106bpromotescellproliferationviatargetingrbinlaryngealcarcinoma
AT wangyu mir106bpromotescellproliferationviatargetingrbinlaryngealcarcinoma
AT caikemin mir106bpromotescellproliferationviatargetingrbinlaryngealcarcinoma